Dr. Beeram is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4383 Medical Dr
Fl 3
San Antonio, TX 78229Phone+1 210-593-5700Fax+1 210-617-7021
Education & Training
University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2003
SUNY Downstate Health Sciences University/Long Island College HospitalResidency, Internal Medicine, 1997 - 2000
Osmania Medical College NTR UHSClass of 1994
Certifications & Licensure
TX State Medical License 2005 - 2025
Clinical Trials
- Erlotinib, Trastuzumab, and Paclitaxel in Treating Patients With Advanced Solid Tumors Start of enrollment: 2002 May 01
- Sorafenib and Temsirolimus in Treating Patients With Unresectable or Metastatic Solid Tumors Start of enrollment: 2005 Sep 01
- Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment Start of enrollment: 2012 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 515 citationsPhase I Study of Pembrolizumab (MK-3475; Anti–PD-1 Monoclonal Antibody) in Patients with Advanced Solid TumorsAmita Patnaik, S. Peter Kang, Drew W. Rasco, Kyriakos P. Papadopoulos, Jeroen Elassaiss-Schaap
Clinical Cancer Research. 2015-05-14 - 36 citationsClinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumorsAmita Patnaik, Anthony W. Tolcher, Murali Beeram, John Nemunaitis, Glen J. Weiss
Cancer Chemotherapy and Pharmacology. 2015-07-26 - 189 citationsDouble-Blind Randomized Phase II Study of the Combination of Sorafenib and Dacarbazine in Patients With Advanced Melanoma : A Report From the 11715 Study GroupDavid F. McDermott, Jeffrey A. Sosman, Rene Gonzalez, F. Stephen Hodi, Gerald P. Linette
Journal of Clinical Oncology. 2008-05-01
Press Mentions
Combinations with Abemaciclib Show Long-Term Disease Control in Advanced Breast CancerOctober 19th, 2016
Professional Memberships
- Member
- American Association for Cancer ResearchMember
Other Languages
- Spanish, Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
